A pathological role of EGFR signaling has been demonstrated in CNS neurodegenerative diseases, including SCI, AD, brain ischemia and subarachnoid hemorrhage [10, 13–15, 19] but not ICH. This evidence concerns the gene EGFR and Alzheimer disease.